The Restart Life Sciences product relaunch marks a significant step in the company’s broader commercial growth strategy. The Canadian life sciences group has advanced preparations for the reintroduction of a flagship healthcare product acquired through a strategic intellectual property licensing agreement.
Moreover, the initiative demonstrates a disciplined approach to capital...
There is something deceptively understated about this AI-first C-suite transformation. Beneath the polished optimism of corporate press releases lies...
